Perspectives in ADHF Management: Thresholds for Pharmacotherapy
(I3529-06-R)
|
| Please note that there is a typographical error in the early
printing of the
"Currently Used In-Hospital Treatments for the Management of Acute Decompensated Heart Failure Table."
In some of the printed versions, there is the following error: Dosage Column,
Natriuretic Peptides/Nesiritide, final bullet should read:
When necessary, the infusion dose of nesiritide can be increased.
In the VMAC trial there was limited experience with increasing the
doses in patients who had central hemodynamic monitoring as follows:
0.005 μg/kg/min (preceded by a bolus of 1 μg/kg),
no more frequently than every 3 hours up to a maximum dose of 0.03
μg/kg/min. Nesiritide should not be titrated at frequent intervals
as is done with other IV agents that have a shorter half-life.
In the printing process, the μ symbol was
incorrectly converted.
We are sorry for any inconvenience this might
have caused. |
Perspectives in ADHF Management, Thresholds for
Pharmacotherapy is pharmacotherapy primer and safety reference guide that
summarizes each therapeutic drug category, its current indications and use in
the management of acute decompensated heart failure (ADHF), proper dosage
guidelines, and relevant safety, data including renal function and mortality.
The activity has been planned and implemented in accordance with the Essential
Areas and Policies of the Accreditation Council for Continuing Medical Education
through the joint sponsorship of Penn State College of Medicine and SynerMed
Communications. Penn State College of Medicine is accredited by the ACCME to
provide continuing medical education for physicians.
Penn State designates this activity for a maximum of 1 category 1 credit toward
the AMA Physician's Recognition Award. Each physician should claim only those
credits that he/she actually spent in the activity.
This self-study learning program is designed for cardiologists, hospitalists,
and emergency physicians.
Continuing Medical Education credit will be awarded to physicians who
successfully complete this activity. Participation should take approximately 1
hour. To complete the activity and receive credit:
-
Read the educational objectives
-
Read and review the primer
-
Complete an online posttest and evaluation form. For a
printed copy of the posttest and evaluation materials, contact Penn State
Continuing Education and ask for the Enduring Materials Coordinator.
Penn State Continuing Education, G220
P.O. Box 851 Hershey PA 17033
Phone: 717-531-6483
Fax: 717-531-5604
ContinuingEd@hmc.psu.edu
*If you do not have a copy of the educational material, please contact
Continuing Education using the link below. The materials are also available to
download in a pdf format:
You must receive a score of 80% or better to receive credit. Be
sure to submit the post-test and the evaluation form on or before April 30, 2008. After this date the article will no longer be designated for credit.
A CME certificate will be mailed within 6-8 weeks. It is
recommended that you print and retain a copy of your completed evaluation and
post-test until you receive your certificate.
For questions, please contact Penn
State Continuing Education at 717-531-6483, or ContinuingEd@hmc.psu.edu.
Please reference activity code I3529-06-R, Perspectives in ADHF Management:
Thresholds for Pharmacotherapy.
Privacy Statement This statement has been
developed to demonstrate the commitment of Penn State College of Medicine to
on-line privacy. It discloses our information-gathering and dissemination
practices for this website. You may visit this website without
submitting any information about yourself. If you send us an e-mail or choose to
participate in the on-line post-test and evaluation, you will be asked to submit
information about yourself. We will use this information to document your
participation in the educational activity. We will record and store all
information you submit. Records of your participation will be retained and
submitted in aggregate to the appropriate accrediting bodies to document your
participation and credit earned. We may use the information you
submit to contact you concerning this educational activity or other relevant
educational activities presented by us or qualified educational partners.
Our website logs the IP address of visitors to administer the
site, regulate submission of Continuing Education tests and evaluation forms,
and to diagnose problems with our server. IP addresses are not used to identify
individuals. This policy pertains only to this Website and does
not extend to links to other organizations included as part of this site.
Penn State Continuing Education will not intentionally share the contents of any
e-mail with anyone other than our educational partners, or website
administrator, however, due to the nature of electronic communications we cannot
provide any assurances that the content of your e-mail or submitted information
will not become known or accessible to any third parties.
|
